Novonesis (NZYMB) Stock Overview
Produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
NZYMB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Novonesis A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 45.21 |
| 52 Week High | DKK 0 |
| 52 Week Low | DKK 0 |
| Beta | 0.54 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | 0.022% |
| 5 Year Change | 0.022% |
| Change since IPO | 3.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| NZYMB | CH Chemicals | CH Market | |
|---|---|---|---|
| 7D | 0% | 1.7% | 3.5% |
| 1Y | 0% | -27.8% | 2.9% |
Return vs Industry: NZYMB underperformed the Swiss Chemicals industry which returned 5.2% over the past year.
Return vs Market: NZYMB underperformed the Swiss Market which returned 6.3% over the past year.
Price Volatility
| NZYMB volatility | |
|---|---|
| NZYMB Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 2.6% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in CH Market | 7.6% |
| 10% least volatile stocks in CH Market | 1.7% |
Stable Share Price: NZYMB's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: Insufficient data to determine NZYMB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1925 | 10,452 | Ester Baiget | www.novonesis.com |
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Novonesis A/S Fundamentals Summary
| NZYMB fundamental statistics | |
|---|---|
| Market cap | CHF 24.11b |
| Earnings (TTM) | CHF 262.79m |
| Revenue (TTM) | CHF 2.83b |
Is NZYMB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NZYMB income statement (TTM) | |
|---|---|
| Revenue | €3.04b |
| Cost of Revenue | €1.62b |
| Gross Profit | €1.42b |
| Other Expenses | €1.14b |
| Earnings | €282.79m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 46.66% |
| Net Profit Margin | 9.29% |
| Debt/Equity Ratio | 18.1% |
How did NZYMB perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/27 12:33 |
| End of Day Share Price | 2024/08/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novozymes A/S is covered by 41 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Vitfell-Rasmussen | ABG Sundal Collier |
| Carla Bänziger | Bank Vontobel AG |
| Sebastian Satz | Barclays |